Monica Lynam
Adult Health · Las Vegas, NVNPI 1902511496
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.6% of the total across 241 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Viiv Healthcare Company at 38.3% of the total.
Across 241 payments — averaging $22.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$2K
- Gilead$1K
- AbbVie$663
- Merck$545
- Shionogi Inc$327
- Astellas Pharma US Inc$265
- plus $513 from 10 others
What the payments were for
- Food & beverage$5,29898%
- Education$1302%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 86 | $2,079 |
| Gilead | 49 | $1,036 |
| AbbVie | 31 | $663 |
| Merck | 22 | $545 |
| Shionogi Inc | 20 | $327 |
| Astellas Pharma US Inc | 9 | $265 |
| Paratek Pharmaceuticals, Inc. | 6 | $116 |
| Aimmune Therapeutics, Inc. | 4 | $98 |
| Insmed, Inc. | 4 | $91 |
| Melinta Therapeutics, LLC | 3 | $56 |
| Johnson & Johnson | 2 | $44 |
| Theratechnologies Inc. | 1 | $38 |
| Dynavax Technologies Corporation | 1 | $21 |
| La Jolla Pharmaceutical Company | 1 | $20 |
| Pfizer | 1 | $15 |
| Napo Pharmaceuticals Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,428 in reported general payments places this provider in the 85th percentile of 90 adult health providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 224 | $913,441 |
| DovatoDolutegravir Sodium/Lamivudine | 62 | $185,103 |
| TriumeqAbacavir/Dolutegravir/Lamivudi | 16 | $79,041 |
| DelstrigoDoravirine/Lamivu/Tenofov Diso | 14 | $37,462 |
| DescovyEmtricitabine/Tenofov Alafenam | 12 | $29,175 |
| VemlidyTenofovir Alafenamide | 13 | $18,807 |
| Fosfomycin Tromethamine | 18 | $3,361 |
| Tenofovir Disoproxil Fumarate | 19 | $2,736 |
| Rifampin | 30 | $1,891 |
| Azithromycin | 31 | $1,181 |
| Ethambutol Hcl | 14 | $873 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 42 | $661 |
| Cephalexin | 13 | $594 |
| Fluconazole | 19 | $362 |
| Isoniazid | 51 | $327 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Descovy, Vemlidy | $1,036 | $961,424249 claims |
| Viiv Healthcare CompanyDovato, Triumeq | $2,079 | $264,14578 claims |
| MerckDelstrigo | $545 | $37,46214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 90 adult health providers in Nevada.
Other adult health in Las Vegas
- Marcia Castro-RosenbergLas Vegas$64K
- Amanda SquiersLas Vegas$36K
- Jasmina FornbacherLas Vegas$14K
- Marcella PomeranzLas Vegas$14K
- Karisa SonLas Vegas$10K
- Jessica LuceroLas Vegas$6K
- Thomas McNeilLas Vegas$5K
- Roger ConantLas Vegas$4K
- Ruth RamirezLas Vegas$4K
- Gener CruzLas Vegas$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.